FindTrial
Sign In

Study on the Inflammatory Mechanism of Co infection of Respiratory Infectious Diseases and COVID-19 Sequelae

Study on the Inflammatory Mechanism of Co infection of Respiratory Infectious Diseases and COVID-19 Sequelae

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115767
Enrollment
Unknown
Registered
2025-12-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Superinfection group and control group:None
Control group:None

Sponsors

First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed COVID-19: The patient must have a confirmed history of COVID-19; 2. Have more than two previous visits to this hospital; 3. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with other serious illnesses or complications; 2. Women who are pregnant or breastfeeding; 3. Patients who have recently received immunosuppressive therapy; 4. Patients unable to comply with the study.

Design outcomes

Primary

MeasureTime frame
Incidence of PASC and DALY;—

Secondary

MeasureTime frame
Peripheral blood immune-inflammatory cells, gene transcripts, protein expression, levels of immune-inflammatory responses, and indicators related to glucose and lipid metabolism;—

Countries

China

Contacts

Public ContactQin Hao

First Affiliated Hospital of Naval Medical University

qinhaosmmu@163.com+86 21 31161316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026